(0.23%) 5 143.25 points
(0.11%) 38 483 points
(0.37%) 17 912 points
(-0.86%) $83.13
(0.94%) $1.941
(-0.09%) $2 345.10
(-0.04%) $27.53
(2.20%) $942.35
(-0.15%) $0.933
(-0.11%) $11.01
(-0.32%) $0.798
(1.29%) $93.06
@ $17.66
Išleistas: 14 vas. 2024 @ 20:37
Grąža: -6.17%
Ankstesnis signalas: vas. 14 - 19:03
Ankstesnis signalas:
Grąža: 1.15 %
Live Chart Being Loaded With Signals
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access...
Stats | |
---|---|
Šios dienos apimtis | 321 644 |
Vidutinė apimtis | 527 866 |
Rinkos kapitalizacija | 2.65B |
EPS | $0 ( 2024-02-29 ) |
Kita pelno data | ( $0.100 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -47.34 |
ATR14 | $0.0120 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Feehery William F | Buy | 124 779 | Restricted Stock Units |
2024-04-02 | Smith Patrick F | Sell | 5 264 | Common Stock |
2024-04-02 | Smith Patrick F | Sell | 649 | Common Stock |
2024-04-02 | Smith Patrick F | Sell | 3 024 | Common Stock |
2024-04-02 | Smith Patrick F | Sell | 328 | Common Stock |
INSIDER POWER |
---|
30.50 |
Last 100 transactions |
Buy: 798 344 | Sell: 442 671 |
Tūris Koreliacija
Certara, Inc. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RELY | 0.963 |
MSAC | 0.958 |
KAII | 0.953 |
ALTR | 0.951 |
APXI | 0.95 |
LMB | 0.946 |
AEAC | 0.945 |
ANSS | 0.944 |
MLAI | 0.944 |
DSEY | 0.943 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
GOOD | -0.959 |
CSSEP | -0.958 |
HALO | -0.955 |
CBNK | -0.952 |
SFST | -0.947 |
WASH | -0.947 |
WTBA | -0.946 |
MCBS | -0.946 |
UTHR | -0.946 |
BMRA | -0.945 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Certara, Inc. Koreliacija - Valiuta/Žaliavos
Certara, Inc. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $354.34M |
Bruto pelnas: | $167.79M (47.35 %) |
EPS: | $-0.350 |
FY | 2023 |
Pajamos: | $354.34M |
Bruto pelnas: | $167.79M (47.35 %) |
EPS: | $-0.350 |
FY | 2022 |
Pajamos: | $335.64M |
Bruto pelnas: | $203.07M (60.50 %) |
EPS: | $0.0939 |
FY | 2021 |
Pajamos: | $286.10M |
Bruto pelnas: | $174.49M (60.99 %) |
EPS: | $-0.0900 |
Financial Reports:
No articles found.
Certara, Inc.
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.